Though not attaining statistical significance, treatment led to a clear trend of dose-dependent improvement in this activity at both ages ( Fig. 7 F).
← all excerpts
FRRS1L gene replacement ameliorates disease phenotypes in the mouse model of developmental and epileptic encephalopathy 37.
1
—
—